MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

Search

Stryker Corp

Closed

SectorHealthcare

360.88 0.87

Overview

Share price change

24h

Current

Min

353.66

Max

361.08

Key metrics

By Trading Economics

Income

-288M

546M

Sales

946M

6.4B

P/E

Sector Avg

43.649

57.333

EPS

4.01

Dividend yield

0.99

Profit margin

8.484

Employees

53,000

EBITDA

385M

1.8B

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+20.25% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.99%

2.63%

Next Earnings

1 May 2025

Next Dividend date

30 Apr 2025

Market Stats

By TradingEconomics

Market Cap

-18B

132B

Previous open

360.01

Previous close

360.88

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

Stryker Corp Chart

Past performance is not a reliable indicator of future results.

Related News

28 Jan 2025, 21:55 UTC

Earnings

Stryker Sees Further Organic Sales Growth in 2025

28 Jan 2025, 21:46 UTC

Acquisitions, Mergers, Takeovers

Stryker to Sell Spinal Implants Business to Viscogliosi Brothers

6 Jan 2025, 22:18 UTC

Acquisitions, Mergers, Takeovers

Stryker to Acquire Inari Medical in Deal Valued at $4.9 Billion -- Update

6 Jan 2025, 21:39 UTC

Acquisitions, Mergers, Takeovers

Stryker to Acquire Inari Medical in Deal Valued at $4.9 Billion

19 Feb 2025, 13:53 UTC

Acquisitions, Mergers, Takeovers

Stryker Files 8K - Asset Acquisition Or Disposition >SYK

19 Feb 2025, 13:30 UTC

Acquisitions, Mergers, Takeovers

Stryker Completes Acquisition Of Inari Medical, Inc., Providing Entry Into The High-growth Peripheral Vascular Segment >SYK

28 Jan 2025, 21:09 UTC

Acquisitions, Mergers, Takeovers

Stryker: Transaction Is Expected to Close in the U.S. in 1H 2025 >SYK

28 Jan 2025, 21:09 UTC

Acquisitions, Mergers, Takeovers

Stryker: Agreement Includes Binding Offer to Acquire Stryker's Spinal Implants Business in France >SYK

28 Jan 2025, 21:08 UTC

Acquisitions, Mergers, Takeovers

Stryker: After Closing, VB Spine Will Become a Strategic Partner to Stryker With Exclusive Access to Mako Spine and Copilot for Use With VB Spine's Implants in Spine Procedures >SYK

28 Jan 2025, 21:08 UTC

Acquisitions, Mergers, Takeovers

Stryker: Agreement to Sell U.S. Spinal Implants Business to Viscogliosi Brothers, LLC to Create Newly Formed Co Called VB Spine, LLC >SYK

28 Jan 2025, 21:06 UTC

Earnings

Stryker Sees Organic Net Sales Growth of 8% to 9% for 2025 >SYK

28 Jan 2025, 21:06 UTC

Earnings

Stryker Sees FY Adj EPS $13.45-Adj EPS $13.70 >SYK

28 Jan 2025, 21:05 UTC

Acquisitions, Mergers, Takeovers

Stryker: Announces Definitive Agreement for the Sale of U.S. Spinal Implants Business and Plans to Sell Related Intl Business

28 Jan 2025, 21:05 UTC

Earnings

Stryker 4Q Net $500M >SYK

28 Jan 2025, 21:05 UTC

Earnings

Stryker 4Q Adj EPS $4.01 >SYK

28 Jan 2025, 21:05 UTC

Earnings

Stryker 4Q Net $546M >SYK

28 Jan 2025, 21:05 UTC

Earnings

Stryker 4Q Net $500M >SYK

28 Jan 2025, 21:05 UTC

Earnings

Stryker 4Q Sales $6.4B >SYK

28 Jan 2025, 21:05 UTC

Earnings

Stryker 4Q EPS $1.41 >SYK

28 Jan 2025, 21:05 UTC

Earnings

Stryker 4Q Adj EPS $4.01 >SYK

28 Jan 2025, 21:05 UTC

Earnings

Stryker 4Q EPS $1.41 >SYK

28 Jan 2025, 21:05 UTC

Earnings

Stryker 4Q Sales $6.4B >SYK

17 Jan 2025, 21:20 UTC

Acquisitions, Mergers, Takeovers

Stryker Commences Tender Offer for All Outstanding Shrs of Common Stock of Inari Medical

13 Jan 2025, 19:30 UTC

Earnings

Update: Stryker Had A Good Year Last Year; Here's How It's Looking For 2025 -- IBD

7 Jan 2025, 09:58 UTC

Hot Stocks

Stocks to Watch Tuesday: Nvidia, Uber, Tencent -- WSJ

6 Jan 2025, 22:03 UTC

Top News
Acquisitions, Mergers, Takeovers

Stryker to Acquire Inari Medical in Deal Valued at $4.9B -- Update

6 Jan 2025, 21:49 UTC

Acquisitions, Mergers, Takeovers

Inari Medical Catapults -- Again -- After Stryker Confirms $4.9 Billion Deal -- IBD

6 Jan 2025, 21:24 UTC

Top News
Acquisitions, Mergers, Takeovers

Stryker to Acquire Inari Medical in Deal Valued at $4.9B

6 Jan 2025, 21:11 UTC

Acquisitions, Mergers, Takeovers

Stryker: Inari's Innovative Pdt Portfolio Is Highly Complementary to Our Neurovascular Business >SYK

6 Jan 2025, 21:10 UTC

Acquisitions, Mergers, Takeovers

Stryker: Transaction Is Anticipated to Close by the End of the 1Q >SYK

Peer Comparison

Price change

Stryker Corp Forecast

Price Target

By TipRanks

20.25% upside

12 Months Forecast

Average 434.15 USD  20.25%

High 465 USD

Low 390 USD

Based on 21 Wall Street analysts offering 12 month price targets forStryker Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

21 ratings

17

Buy

4

Hold

0

Sell

Technical Score

By Trading Central

345.99 / 368.365Support & Resistance

Short Term

Strong Bullish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Strong Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.